GENE ONLINE|News &
Opinion
Blog

2026-06-01|

Medicare to Cover Wegovy and Zepbound in July for $50 a Month, Cost Estimate Still Unknown

by GOAI
Share To

**Medicare’s Coverage of Obesity Drugs Begins in July, Cost Estimate Still Undisclosed**

Starting in July, Medicare will cover Wegovy and Zepbound for older adults, making these weight-loss drugs available for approximately $50 a month. However, the agency has not yet released an estimate of the total cost to taxpayers for this new coverage.

The introduction of this coverage marks a significant expansion in Medicare benefits, potentially providing affordable access to these medications for many older adults. Despite the impending start date, the financial implications of this program remain unclear, as the agency has not shared details regarding the projected overall expense.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 1, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
nVent Electric Appoints New Chief Strategy and Revenue Officers
2026-06-10
Snail Games Announces Bellwright Console Launch and New ARK Content at IGN Live 2026
2026-06-10
BJJLink Launches AI-Powered Platform for Martial Arts Gym Member Acquisition
2026-06-10
Trump Media and TAE Technologies Provide Merger Status Update on June 10, 2026
2026-06-10
OZOP Energy Solutions Partners with Tenace Consulting for Southern California Distribution
2026-06-10
Agassi Sports Entertainment Signs Darren Cahill to Lead Global Coaching and Technology Initiatives
2026-06-10
Scroll to Top